Geron (GERN) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Geron Revenue Highlights


Latest Revenue (Y)

$237.00K

Latest Revenue (Q)

$28.21M

Geron Revenue by Period


Geron Revenue by Year

DateRevenueChange
2023-12-31$237.00K-60.23%
2022-12-31$596.00K-57.21%
2021-12-31$1.39M450.59%
2020-12-31$253.00K-45.00%
2019-12-31$460.00K-56.85%
2018-12-31$1.07M0.09%
2017-12-31$1.06M-82.72%
2016-12-31$6.16M-83.06%
2015-12-31$36.37M3054.47%
2014-12-31$1.15M-10.13%
2013-12-31$1.28M-52.64%
2012-12-31$2.71M11.12%
2011-12-31$2.44M-31.57%
2010-12-31$3.56M106.43%
2009-12-31$1.73M-38.42%
2008-12-31$2.80M-63.22%
2007-12-31$7.62M132.59%
2006-12-31$3.28M1030.00%
2005-12-31$290.00K-72.46%
2004-12-31$1.05M-10.31%
2003-12-31$1.17M-5.93%
2002-12-31$1.25M-65.52%
2001-12-31$3.62M-45.23%
2000-12-31$6.61M22.39%
1999-12-31$5.40M-20.59%
1998-12-31$6.80M-6.85%
1997-12-31$7.30M37.74%
1996-12-31$5.30M-

Geron generated $237.00K in revenue during NA 2023, up -60.23% compared to the previous quarter, and up 22.23% compared to the same period a year ago.

Geron Revenue by Quarter

DateRevenueChange
2024-09-30$28.21M3098.30%
2024-06-30$882.00K190.13%
2024-03-31$304.00K1221.74%
2023-12-31$23.00K-85.98%
2023-09-30$164.00K465.52%
2023-06-30$29.00K38.10%
2023-03-31$21.00K-79.61%
2022-12-31$103.00K-65.32%
2022-09-30$297.00K306.85%
2022-06-30$73.00K-40.65%
2022-03-31$123.00K-88.17%
2021-12-31$1.04M854.13%
2021-09-30$109.00K1.87%
2021-06-30$107.00K-21.90%
2021-03-31$137.00K174.00%
2020-12-31$50.00K-53.70%
2020-09-30$108.00K151.16%
2020-06-30$43.00K-17.31%
2020-03-31$52.00K-69.59%
2019-12-31$171.00K30.53%
2019-09-30$131.00K29.70%
2019-06-30$101.00K77.19%
2019-03-31$57.00K-84.80%
2018-12-31$375.00K127.27%
2018-09-30$165.00K-20.67%
2018-06-30$208.00K-34.59%
2018-03-31$318.00K66.49%
2017-12-31$191.00K17.18%
2017-09-30$163.00K-6.32%
2017-06-30$174.00K-67.60%
2017-03-31$537.00K471.28%
2016-12-31$94.00K-98.16%
2016-09-30$5.11M2320.85%
2016-06-30$211.00K-71.83%
2016-03-31$749.00K240.45%
2015-12-31$220.00K-99.38%
2015-09-30$35.36M13988.84%
2015-06-30$251.00K-53.26%
2015-03-31$537.00K201.69%
2014-12-31$178.00K11.25%
2014-09-30$160.00K-53.08%
2014-06-30$341.00K-28.06%
2014-03-31$474.00K110.67%
2013-12-31$225.00K24.31%
2013-09-30$181.00K61.61%
2013-06-30$112.00K-85.36%
2013-03-31$765.00K11.03%
2012-12-31$689.00K8.33%
2012-09-30$636.00K389.23%
2012-06-30$130.00K-89.63%
2012-03-31$1.25M399.60%
2011-12-31$251.00K14.09%
2011-09-30$220.00K-52.38%
2011-06-30$462.00K-69.30%
2011-03-31$1.50M37.07%
2010-12-31$1.10M101.10%
2010-09-30$546.00K-45.45%
2010-06-30$1.00M9.04%
2010-03-31$918.00K51.74%
2009-12-31$605.00K22.47%
2009-09-30$494.00K169.95%
2009-06-30$183.00K-58.78%
2009-03-31$444.00K-18.38%
2008-12-31$544.00K48.23%
2008-09-30$367.00K85.35%
2008-06-30$198.00K-88.31%
2008-03-31$1.69M-63.86%
2007-12-31$4.69M-

Geron generated $28.21M in revenue during Q3 2024, up 3098.30% compared to the previous quarter, and up 97272.41% compared to the same period a year ago.

Geron Revenue Breakdown


Geron Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 24
Chargeback And Distributor Service Fees$-4.00M
Government Rebates$-364.00K
Product$28.21M
Revenues Before Adjustments$32.66M
Sales Returns And Allowance$-82.00K
Total Gross To Net Adjustments$-4.45M

Geron's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Revenues Before Adjustments (62.84%), Product (54.28%), Sales Returns And Allowance (-0.16%), Government Rebates (-0.70%), Chargeback And Distributor Service Fees (-7.70%), and Total Gross To Net Adjustments (-8.56%).

Geron Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SRPTSarepta Therapeutics$1.24B$362.93M
PTCTPTC Therapeutics$937.82M$135.42M
TGTXTG Therapeutics$233.66M$83.88M
GERNGeron$237.00K$28.21M
CWBRCohBar--
XFORX4 Pharmaceuticals-$563.00K
AVROAVROBIO--
VKTXViking Therapeutics--
PDSBPDS Bio--
ZURAZura Bio--
ELEVElevation Oncology--
MDGLMadrigal Pharmaceuticals-$62.17M
OCEAOcean Biomedical--
IMMXImmix Biopharma--
HEPAHepion Pharmaceuticals--
ENVBEnveric Biosciences--
EFTReFFECTOR Therapeutics--

GERN Revenue FAQ


Geron's yearly revenue for 2023 was $237K, representing a decrease of -60.23% compared to 2022. The company's yearly revenue for 2022 was $596K, representing a decrease of -57.21% compared to 2021. GERN's yearly revenue for 2021 was $1.39M, representing an increase of 450.59% compared to 2020.

Geron's quarterly revenue for Q3 2024 was $28.21M, a 3098.30% increase from the previous quarter (Q2 2024), and a 17100.61% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $882K, a 190.13% increase from the previous quarter (Q1 2024), and a 2941.38% increase year-over-year (Q2 2023). GERN's quarterly revenue for Q1 2024 was $304K, a 1221.74% increase from the previous quarter (Q4 2023), and a 1347.62% increase year-over-year (Q1 2023).

Geron's revenue growth rate for the last 3 years (2021-2023) was -82.99%, and for the last 5 years (2019-2023) was -48.48%.